PGR and ductal breast carcinoma in situ: Furthermore, given the high rate of ER and PR positivity in DCIS, hormone receptor negative DCIS cases are acutely under-represented, hindering comparison of recurrence rates between these groups and impacting the statistical strength of these studies.